Aasld 2024 Abstract. Chosen from a highly qualified applicant pool. This study assessed the impact of histological.
Galt), the leading developer of therapeutics that target galectin proteins,. Chosen from a highly qualified applicant pool.
Aasld 2024 Abstract Images References :